*Scott Fletcher also holds 15,936,000 warrant instruments, which if exercised, would take his holding to 33.4% of the company’s enlarged share capital, assuming that no other warrants are exercised.
**Seritza Limited is a private company owned by a trust of which Chief Executive Officer, Hanno Pengilly, is a potential beneficiary.
*** Michael Haworth SGN's non-executive chairman holds 10,826,416 shares in his own name and 13,110,133 through a trust. He also holds 3,264,000 warrant instruments, which if exercised, would take his holding to 4.8% of the company’s enlarged share capital, assuming that no other warrants are exercised.
****Mrs & Mr Weatherhead also hold 2,307,700 warrant instruments, which if exercised, would take their holding to 3.66% of the company’s enlarged share capital, assuming that no other warrants are exercised.
Africa Finance Corporation
Mrs & Mr Weatherhead****
As at: 7 June 2023
Shares with voting rights
Shares in issue
Shares not in public hands
Nominated Adviser and Broker
Liberum Capital Limited
Ropemaker Place Level 12
12 Ropemaker Street
London EC2Y 9AR
Novum Securities Limited
8-10 Grosvenor Gardens
London SW1W 0DH
Computershare Investor Services (BVI) Limited
PO Box 3162
Road Town Tortola
British Virgin Islands
Computershare Investor Services plc
Bristol BS13 8AE
55 Baker Street
London W1U 7EU
Simmons & Simmons LLP
1 Ropemaker Street
London EC2R 7HF
Enviromental & Social
Impacto Av. Mártires da Machava,
968 Maputo, Mozambique
Coastal Building, Wickham's Cay II
PO Box 2221
British Virgin Islands
AIM Rule 26
Last updated: 6 March 2023
Company Information Disclosure
The following information is disclosed in accordance with Rule 26 of the AIM Rules for Companies.
Please follow this link for a description of the business. Incorporation and Operation Solgenics Limited was incorporated in the British Virgin Islands (registration number 1019077) as a BVIBC with limited liability under the BVI act. Its main country of operation is Mozambique.
The rights of shareholders may be different from the rights of shareholders in a UK incorporated company. Solgenics Limited is not subject to the City Code on Takeovers and Mergers.
Please follow this link for a copy of the current memorandum and articles of association (PDF 421 KB). Directors Please follow this link for the names of the Directors and their biographies. Corporate governance and internal controls
Please follow this link for details of the responsibilities of the Board, corporate governance committees and Solgenics' compliance with the UK Combined Code.
Exchanges and Platforms Solgenics ordinary shares are admitted to trading on the AIM. The Company has not applied to have any of its securities admitted on any other exchange.
Securities in Issue
Securities not in Public Hands
Significant Shareholders (as at 9 February 2023)
Please follow this link to access the significant shareholders
Restrictions on Transfer
There are currently no restrictions on the transfer of securities.
Documentation and Announcements
Please follow this link to access the AIM admission document (PDF 20.3MB).
Access all circulars and similar publications sent to shareholders within the past 12 months.
Access all notifications made it the past 12 months.
Access all the Company's financial statements here.
Read more about details of Solgenics’ nominated adviser and other key advisors below